Literature DB >> 22144487

Free lipid A isolated from Porphyromonas gingivalis lipopolysaccharide is contaminated with phosphorylated dihydroceramide lipids: recovery in diseased dental samples.

Frank C Nichols1, Bekim Bajrami, Robert B Clark, William Housley, Xudong Yao.   

Abstract

Recent reports indicate that Porphyromonas gingivalis mediates alveolar bone loss or osteoclast modulation through engagement of Toll-like receptor 2 (TLR2), though the factors responsible for TLR2 engagement have yet to be determined. Lipopolysaccharide (LPS) and lipid A, lipoprotein, fimbriae, and phosphorylated dihydroceramides of P. gingivalis have been reported to activate host cell responses through engagement of TLR2. LPS and lipid A are the most controversial in this regard because conflicting evidence has been reported concerning the capacity of P. gingivalis LPS or lipid A to engage TLR2 versus TLR4. In the present study, we first prepared P. gingivalis LPS by the Tri-Reagent method and evaluated this isolate for contamination with phosphorylated dihydroceramide lipids. Next, the lipid A prepared from this LPS was evaluated for the presence of phosphorylated dihydroceramide lipids. Finally, we characterized the lipid A by the matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) and electrospray-MS methods in order to quantify recovery of lipid A in lipid extracts from diseased teeth or subgingival plaque samples. Our results demonstrate that both the LPS and lipid A derived from P. gingivalis are contaminated with phosphorylated dihydroceramide lipids. Furthermore, the lipid extracts derived from diseased teeth or subgingival plaque do not contain free lipid A constituents of P. gingivalis but contain substantial amounts of phosphorylated dihydroceramide lipids. Therefore, the free lipid A of P. gingivalis is not present in measurable levels at periodontal disease sites. Our results also suggest that the TLR2 activation of host tissues attributed to LPS and lipid A of P. gingivalis could actually be mediated by phosphorylated dihydroceramides.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22144487      PMCID: PMC3264315          DOI: 10.1128/IAI.06180-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2.

Authors:  Y Asai; Y Ohyama; K Gen; T Ogawa
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.

Authors:  M Hirschfeld; J J Weis; V Toshchakov; C A Salkowski; M J Cody; D C Ward; N Qureshi; S M Michalek; S N Vogel
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction.

Authors:  George Hajishengallis; Michael Martin; Hakimuddin T Sojar; Ashu Sharma; Robert E Schifferle; Ernesto DeNardin; Michael W Russell; Robert J Genco
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation.

Authors:  Richard P Darveau; Saman Arbabi; Iris Garcia; Brian Bainbridge; Ronald V Maier
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

6.  Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4.

Authors:  Richard P Darveau; Thu-Thao T Pham; Kayde Lemley; Robert A Reife; Brian W Bainbridge; Stephen R Coats; William N Howald; Sing Sing Way; Adeline M Hajjar
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Endotoxic and immunobiological activities of a chemically synthesized lipid A of Helicobacter pylori strain 206-1.

Authors:  Tomohiko Ogawa; Yasuyuki Asai; Yasuhiro Sakai; Masato Oikawa; Koichi Fukase; Yasuo Suda; Shoichi Kusumoto; Toshihide Tamura
Journal:  FEMS Immunol Med Microbiol       Date:  2003-05-15

8.  Quadrupole ion-trap mass spectrometry to locate fatty acids on lipid A from Gram-negative bacteria.

Authors:  Anders Kussak; Andrej Weintraub
Journal:  Anal Biochem       Date:  2002-08-01       Impact factor: 3.365

9.  Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Frank C Gibson; Charlie Hong; Hsin-Hua Chou; Hiromichi Yumoto; Jiqiu Chen; Egil Lien; Jodie Wong; Caroline Attardo Genco
Journal:  Circulation       Date:  2004-05-03       Impact factor: 29.690

10.  The structurally similar, penta-acylated lipopolysaccharides of Porphyromonas gingivalis and Bacteroides elicit strikingly different innate immune responses.

Authors:  Alex B Berezow; Robert K Ernst; Stephen R Coats; Pamela H Braham; Lisa M Karimi-Naser; Richard P Darveau
Journal:  Microb Pathog       Date:  2009-05-19       Impact factor: 3.738

View more
  18 in total

1.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

2.  Biologic activity of porphyromonas endodontalis complex lipids.

Authors:  Christopher S Mirucki; Mehran Abedi; Jin Jiang; Qiang Zhu; Yu-Hsiung Wang; Kamran E Safavi; Robert B Clark; Frank C Nichols
Journal:  J Endod       Date:  2014-04-13       Impact factor: 4.171

3.  Glycine Lipids of Porphyromonas gingivalis Are Agonists for Toll-Like Receptor 2.

Authors:  Frank C Nichols; Robert B Clark; Yaling Liu; Anthony A Provatas; Christopher J Dietz; Qiang Zhu; Yu-Hsiung Wang; Michael B Smith
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

4.  Serine lipids of Porphyromonas gingivalis are human and mouse Toll-like receptor 2 ligands.

Authors:  Robert B Clark; Jorge L Cervantes; Mark W Maciejewski; Vahid Farrokhi; Reza Nemati; Xudong Yao; Emily Anstadt; Mai Fujiwara; Kyle T Wright; Caroline Riddle; Carson J La Vake; Juan C Salazar; Sydney Finegold; Frank C Nichols
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

5.  A novel class of lipoprotein lipase-sensitive molecules mediates Toll-like receptor 2 activation by Porphyromonas gingivalis.

Authors:  Sumita Jain; Stephen R Coats; Ana M Chang; Richard P Darveau
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

Review 6.  Are Sphingolipids and Serine Dipeptide Lipids Underestimated Virulence Factors of Porphyromonas gingivalis?

Authors:  Ingar Olsen; Frank C Nichols
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

7.  Different effects of Porphyromonas gingivalis lipopolysaccharide and TLR2 agonist Pam3CSK4 on the adhesion molecules expression in endothelial cells.

Authors:  Oleh Andrukhov; Ilse Steiner; Shutai Liu; Hans Peter Bantleon; Andreas Moritz; Xiaohui Rausch-Fan
Journal:  Odontology       Date:  2013-12-29       Impact factor: 2.634

8.  Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.

Authors:  Adel Ersek; Anastasios Karadimitris; Nicole J Horwood
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-23       Impact factor: 5.555

9.  Distinct gene signatures in aortic tissue from ApoE-/- mice exposed to pathogens or Western diet.

Authors:  Carolyn D Kramer; Ellen O Weinberg; Adam C Gower; Xianbao He; Samrawit Mekasha; Connie Slocum; Lea M Beaulieu; Lee Wetzler; Yuriy Alekseyev; Frank C Gibson; Jane E Freedman; Robin R Ingalls; Caroline A Genco
Journal:  BMC Genomics       Date:  2014-12-24       Impact factor: 3.969

10.  Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.

Authors:  Connie Slocum; Stephen R Coats; Ning Hua; Carolyn Kramer; George Papadopoulos; Ellen O Weinberg; Cynthia V Gudino; James A Hamilton; Richard P Darveau; Caroline A Genco
Journal:  PLoS Pathog       Date:  2014-07-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.